Beijing Strong Biotechnologies (SZSE:300406) ROCE % : 12.45% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beijing Strong Biotechnologies's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.45%.

Beijing Strong Biotechnologies ROCE % Historical Data

The historical data trend for Beijing Strong Biotechnologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies ROCE % Chart

Beijing Strong Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

20.65

5.07

15.03

12.51

13.93

Beijing Strong Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															12.86	13.68	13.94	15.33	12.45

Beijing Strong Biotechnologies ROCE % Calculation

Beijing Strong Biotechnologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	640.547	/	( ( (4612.862 - 297.939)	+	(5175.749 - 297.116) )	/ 2 )
	=	640.547	/	( (4314.923	+	4878.633)	/ 2 )
	=	640.547	/	4596.778
	=	13.93 %

Beijing Strong Biotechnologies's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	616.82	/	( ( (5175.749 - 297.116)	+	(5278.102 - 247.583) )	/ 2 )
	=	616.82	/	( ( 4878.633	+	5030.519 )	/ 2 )
	=	616.82	/	4954.576
	=	12.45 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Beijing Strong Biotechnologies (SZSE:300406) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beijing Strong Biotechnologies ROCE % Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Strong Biotechnologies (SZSE:300406) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191

Website

http://www.bsbe.com.cn

Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Executives

Shuang He	Executives
Luo Ai Ping	Director
	Directors, executives
Liu Wei	Executives
Zhou Ming	Executives
Zhuang Xian Min	Directors, executives
Zhang Yi	Executives
Liu Xi	Directors, executives
Sun Xiao Lin	Director
Yu Jian Ping	Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines